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Aim
To highlight the therapeutic and genetic implications of
early diagnosis of HNF-1a mutation in a girl whose
family member had previously been thought to have
type 1 diabetes.
Method
We reported an adolescent girl in whom a diagnosis of
MODY3 was established by molecular finding of a het-
erozygous HNF-1a NM 000545.5: c.775G>T (p.
Val259Phe) mutation. She and her mother now suc-
cessfully manage their diabetes with low dose
sulphonylurea.
Result
A 14 years old girl, who previously had been well, was
incidentally found to have hyperglycemia by her dia-
betic mother. Her body mass index was 19 kg/m2.
General examination was unremarkable without any
acanthosis nigricans. Fasting blood glucose was
6.4mmol/L and 2 hour glucose in oral glucose toler-
ance test was 15.3mmol/L. HbA1c was 7.5%. Fasting
C-peptide was 3.2 µg/L (reference 0.9-7.1µg/L).
Family history revealed that her mother developed dia-
betes at the age of 20 and had been managed as type 1
diabetes with insulin. Mother had satisfactory glycemic
control despite the dosage of insulin remained relatively
low for decade. However, she then got poor compliance
to insulin injection after the age of 40, resulted in wor-
sening of HbA1c to 11-12%. Furthermore, two maternal
aunts were thought to have diabetes, but no further
detail was available.
A diagnosis of MODY was considered for the girl and
molecular analysis confirmed MODY3 with heterozygous
HNF-1a NM 000545.5: c.775G>T (p.Val259Phe) muta-
tion. The patient was initiated on the treatment with low
dose gliclazide. She could achieve good glycemic control
without problem of significant hypoglycemia. Her most
recent HbA1c was 5.7%.
Gene sequencing confirmed that her mother also
harbored the same mutation. After genetic counselling,
insulin therapy of patient ’s mother was gradually
switched to glimepiride by adult endocrinologist. Her
HbA1c showed significant improvement from 12.2% to
7.1%. In addition, no mutation was detected for
patient’s elder sister, indicated that she only had the
population risk of developing diabetes.
Conclusion
Maturity Onset Diabetes of the Young (MODY) is fre-
quently misdiagnosed as type 1 or type 2 diabetes.
MODY3, resulting from a mutation in the HNF-1a
gene, is the most common form of MODY and low
dose sulphonylurea is highly effective in maintaining a
good glycemic control. Early awareness of MODY and
confirmation of subtypes by molecular analysis is
important in guiding the appropriate treatment, predict-
ing the clinical course, providing genetic counselling
and sometimes, correcting the diagnosis or treatment
for other diabetic family members.
Written informed consent was obtained from the
patient for publication of this abstract and any accom-
panying images. A copy of the written consent is avail-
able for review by the Editor of this journal.
Department of Paediatrics & Adolescent Medicine, Alice Ho Miu Ling
Nethersole Hospital, Hong Kong, China
Wong and Tong International Journal of Pediatric Endocrinology 2015, 2015(Suppl 1):P19
http://www.ijpeonline.com/content/2015/S1/P19
© 2015 Wong and Tong; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Published: 28 April 2015
doi:10.1186/1687-9856-2015-S1-P19
Cite this article as: Wong and Tong: Early identification of monogenic
diabetes: implications on medical treatment and genetic counselling for
an adolescent girl with MODY3. International Journal of Pediatric
Endocrinology 2015 2015(Suppl 1):P19.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wong and Tong International Journal of Pediatric Endocrinology 2015, 2015(Suppl 1):P19
http://www.ijpeonline.com/content/2015/S1/P19
Page 2 of 2
